Design Principles of Concentration-Dependent Transcriptome Deviations in Drug-Exposed Differentiating Stem Cells
Information on design principles governing transcriptome changes upon transition from safe to hazardous drug concentrations or from tolerated to cytotoxic drug levels are important for the application of toxicogenomics data in developmental toxicology. Here, we tested the effect of eight concentrati...
Gespeichert in:
Veröffentlicht in: | Chemical research in toxicology 2014-03, Vol.27 (3), p.408-420 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 420 |
---|---|
container_issue | 3 |
container_start_page | 408 |
container_title | Chemical research in toxicology |
container_volume | 27 |
creator | Waldmann, Tanja Rempel, Eugen Balmer, Nina V König, André Kolde, Raivo Gaspar, John Antonydas Henry, Margit Hescheler, Jürgen Sachinidis, Agapios Rahnenführer, Jörg Hengstler, Jan G Leist, Marcel |
description | Information on design principles governing transcriptome changes upon transition from safe to hazardous drug concentrations or from tolerated to cytotoxic drug levels are important for the application of toxicogenomics data in developmental toxicology. Here, we tested the effect of eight concentrations of valproic acid (VPA; 25–1000 μM) in an assay that recapitulates the development of human embryonic stem cells to neuroectoderm. Cells were exposed to the drug during the entire differentiation process, and the number of differentially regulated genes increased continuously over the concentration range from zero to about 3000. We identified overrepresented transcription factor binding sites (TFBS) as well as superordinate cell biological processes, and we developed a gene ontology (GO) activation profiler, as well as a two-dimensional teratogenicity index. Analysis of the transcriptome data set by the above biostatistical and systems biology approaches yielded the following insights: (i) tolerated (≤25 μM), deregulated/teratogenic (150–550 μM), and cytotoxic (≥800 μM) concentrations could be differentiated. (ii) Biological signatures related to the mode of action of VPA, such as protein acetylation, developmental changes, and cell migration, emerged from the teratogenic concentrations range. (iii) Cytotoxicity was not accompanied by signatures of newly emerging canonical cell death/stress indicators, but by catabolism and decreased expression of cell cycle associated genes. (iv) Most, but not all of the GO groups and TFBS seen at the highest concentrations were already overrepresented at 350–450 μM. (v) The teratogenicity index reflected this behavior, and thus differed strongly from cytotoxicity. Our findings suggest the use of the highest noncytotoxic drug concentration for gene array toxicogenomics studies, as higher concentrations possibly yield wrong information on the mode of action, and lower drug levels result in decreased gene expression changes and thus a reduced power of the study. |
doi_str_mv | 10.1021/tx400402j |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3958134</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1524411226</sourcerecordid><originalsourceid>FETCH-LOGICAL-a464t-ac36f173b3eb6418273b2a58faefa3c6d83e131dec11442edcc4b0ff25040fcb3</originalsourceid><addsrcrecordid>eNptkV9P2zAUxS00tHbdHvYFkF8mbQ8B_0uaviChBhgSEkgDiTfLca47V4kd7KSCbz_TQjUknmzr_nzuvecg9J2SY0oYPRmeBCGCsPUBmtKckSwnlHxCU1IueMZY-TBBX2JcE0ITPv-MJkzwkovFfIr6CqJdOXwbrNO2byFib_DSOw1uCGqw3mUV9OCa9MZ3Qbmog-0H3wGuYGO3RMTW4SqMq-z8qfcRGlxZYyCkLy-AW-E_A3R4CW0bv6JDo9oI317PGbq_OL9b_s6uby6vlmfXmRKFGDKleWHonNcc6kLQkqUrU3lpFBjFddGUHCinDWhKhWDQaC1qYgzLkxFG13yGTne6_Vh3qbxdp5V9sJ0Kz9IrK99XnP0rV34j-SIvKRdJ4OerQPCPI8RBdjbqtIJy4Mcok9FCUMpYkdBfO1QHH2MAs29DiXxJSO4TSuzR_3PtybdIEvBjBygd5dqPwSWbPhD6B0XYm5s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1524411226</pqid></control><display><type>article</type><title>Design Principles of Concentration-Dependent Transcriptome Deviations in Drug-Exposed Differentiating Stem Cells</title><source>ACS Publications</source><source>MEDLINE</source><creator>Waldmann, Tanja ; Rempel, Eugen ; Balmer, Nina V ; König, André ; Kolde, Raivo ; Gaspar, John Antonydas ; Henry, Margit ; Hescheler, Jürgen ; Sachinidis, Agapios ; Rahnenführer, Jörg ; Hengstler, Jan G ; Leist, Marcel</creator><creatorcontrib>Waldmann, Tanja ; Rempel, Eugen ; Balmer, Nina V ; König, André ; Kolde, Raivo ; Gaspar, John Antonydas ; Henry, Margit ; Hescheler, Jürgen ; Sachinidis, Agapios ; Rahnenführer, Jörg ; Hengstler, Jan G ; Leist, Marcel</creatorcontrib><description>Information on design principles governing transcriptome changes upon transition from safe to hazardous drug concentrations or from tolerated to cytotoxic drug levels are important for the application of toxicogenomics data in developmental toxicology. Here, we tested the effect of eight concentrations of valproic acid (VPA; 25–1000 μM) in an assay that recapitulates the development of human embryonic stem cells to neuroectoderm. Cells were exposed to the drug during the entire differentiation process, and the number of differentially regulated genes increased continuously over the concentration range from zero to about 3000. We identified overrepresented transcription factor binding sites (TFBS) as well as superordinate cell biological processes, and we developed a gene ontology (GO) activation profiler, as well as a two-dimensional teratogenicity index. Analysis of the transcriptome data set by the above biostatistical and systems biology approaches yielded the following insights: (i) tolerated (≤25 μM), deregulated/teratogenic (150–550 μM), and cytotoxic (≥800 μM) concentrations could be differentiated. (ii) Biological signatures related to the mode of action of VPA, such as protein acetylation, developmental changes, and cell migration, emerged from the teratogenic concentrations range. (iii) Cytotoxicity was not accompanied by signatures of newly emerging canonical cell death/stress indicators, but by catabolism and decreased expression of cell cycle associated genes. (iv) Most, but not all of the GO groups and TFBS seen at the highest concentrations were already overrepresented at 350–450 μM. (v) The teratogenicity index reflected this behavior, and thus differed strongly from cytotoxicity. Our findings suggest the use of the highest noncytotoxic drug concentration for gene array toxicogenomics studies, as higher concentrations possibly yield wrong information on the mode of action, and lower drug levels result in decreased gene expression changes and thus a reduced power of the study.</description><identifier>ISSN: 0893-228X</identifier><identifier>EISSN: 1520-5010</identifier><identifier>DOI: 10.1021/tx400402j</identifier><identifier>PMID: 24383497</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Binding Sites ; Cell Differentiation - drug effects ; Cells, Cultured ; Cluster Analysis ; Down-Regulation - drug effects ; Embryonic Stem Cells - cytology ; Embryonic Stem Cells - drug effects ; Embryonic Stem Cells - metabolism ; Humans ; Neural Plate - cytology ; Neural Plate - metabolism ; Principal Component Analysis ; Transcription Factors - genetics ; Transcription Factors - metabolism ; Transcriptome - drug effects ; Up-Regulation - drug effects ; Valproic Acid - chemistry ; Valproic Acid - toxicity</subject><ispartof>Chemical research in toxicology, 2014-03, Vol.27 (3), p.408-420</ispartof><rights>Copyright © 2014 American Chemical Society</rights><rights>Copyright © 2014 American Chemical Society 2014 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a464t-ac36f173b3eb6418273b2a58faefa3c6d83e131dec11442edcc4b0ff25040fcb3</citedby><cites>FETCH-LOGICAL-a464t-ac36f173b3eb6418273b2a58faefa3c6d83e131dec11442edcc4b0ff25040fcb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/tx400402j$$EPDF$$P50$$Gacs$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/tx400402j$$EHTML$$P50$$Gacs$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24383497$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Waldmann, Tanja</creatorcontrib><creatorcontrib>Rempel, Eugen</creatorcontrib><creatorcontrib>Balmer, Nina V</creatorcontrib><creatorcontrib>König, André</creatorcontrib><creatorcontrib>Kolde, Raivo</creatorcontrib><creatorcontrib>Gaspar, John Antonydas</creatorcontrib><creatorcontrib>Henry, Margit</creatorcontrib><creatorcontrib>Hescheler, Jürgen</creatorcontrib><creatorcontrib>Sachinidis, Agapios</creatorcontrib><creatorcontrib>Rahnenführer, Jörg</creatorcontrib><creatorcontrib>Hengstler, Jan G</creatorcontrib><creatorcontrib>Leist, Marcel</creatorcontrib><title>Design Principles of Concentration-Dependent Transcriptome Deviations in Drug-Exposed Differentiating Stem Cells</title><title>Chemical research in toxicology</title><addtitle>Chem. Res. Toxicol</addtitle><description>Information on design principles governing transcriptome changes upon transition from safe to hazardous drug concentrations or from tolerated to cytotoxic drug levels are important for the application of toxicogenomics data in developmental toxicology. Here, we tested the effect of eight concentrations of valproic acid (VPA; 25–1000 μM) in an assay that recapitulates the development of human embryonic stem cells to neuroectoderm. Cells were exposed to the drug during the entire differentiation process, and the number of differentially regulated genes increased continuously over the concentration range from zero to about 3000. We identified overrepresented transcription factor binding sites (TFBS) as well as superordinate cell biological processes, and we developed a gene ontology (GO) activation profiler, as well as a two-dimensional teratogenicity index. Analysis of the transcriptome data set by the above biostatistical and systems biology approaches yielded the following insights: (i) tolerated (≤25 μM), deregulated/teratogenic (150–550 μM), and cytotoxic (≥800 μM) concentrations could be differentiated. (ii) Biological signatures related to the mode of action of VPA, such as protein acetylation, developmental changes, and cell migration, emerged from the teratogenic concentrations range. (iii) Cytotoxicity was not accompanied by signatures of newly emerging canonical cell death/stress indicators, but by catabolism and decreased expression of cell cycle associated genes. (iv) Most, but not all of the GO groups and TFBS seen at the highest concentrations were already overrepresented at 350–450 μM. (v) The teratogenicity index reflected this behavior, and thus differed strongly from cytotoxicity. Our findings suggest the use of the highest noncytotoxic drug concentration for gene array toxicogenomics studies, as higher concentrations possibly yield wrong information on the mode of action, and lower drug levels result in decreased gene expression changes and thus a reduced power of the study.</description><subject>Binding Sites</subject><subject>Cell Differentiation - drug effects</subject><subject>Cells, Cultured</subject><subject>Cluster Analysis</subject><subject>Down-Regulation - drug effects</subject><subject>Embryonic Stem Cells - cytology</subject><subject>Embryonic Stem Cells - drug effects</subject><subject>Embryonic Stem Cells - metabolism</subject><subject>Humans</subject><subject>Neural Plate - cytology</subject><subject>Neural Plate - metabolism</subject><subject>Principal Component Analysis</subject><subject>Transcription Factors - genetics</subject><subject>Transcription Factors - metabolism</subject><subject>Transcriptome - drug effects</subject><subject>Up-Regulation - drug effects</subject><subject>Valproic Acid - chemistry</subject><subject>Valproic Acid - toxicity</subject><issn>0893-228X</issn><issn>1520-5010</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>N~.</sourceid><sourceid>EIF</sourceid><recordid>eNptkV9P2zAUxS00tHbdHvYFkF8mbQ8B_0uaviChBhgSEkgDiTfLca47V4kd7KSCbz_TQjUknmzr_nzuvecg9J2SY0oYPRmeBCGCsPUBmtKckSwnlHxCU1IueMZY-TBBX2JcE0ITPv-MJkzwkovFfIr6CqJdOXwbrNO2byFib_DSOw1uCGqw3mUV9OCa9MZ3Qbmog-0H3wGuYGO3RMTW4SqMq-z8qfcRGlxZYyCkLy-AW-E_A3R4CW0bv6JDo9oI317PGbq_OL9b_s6uby6vlmfXmRKFGDKleWHonNcc6kLQkqUrU3lpFBjFddGUHCinDWhKhWDQaC1qYgzLkxFG13yGTne6_Vh3qbxdp5V9sJ0Kz9IrK99XnP0rV34j-SIvKRdJ4OerQPCPI8RBdjbqtIJy4Mcok9FCUMpYkdBfO1QHH2MAs29DiXxJSO4TSuzR_3PtybdIEvBjBygd5dqPwSWbPhD6B0XYm5s</recordid><startdate>20140317</startdate><enddate>20140317</enddate><creator>Waldmann, Tanja</creator><creator>Rempel, Eugen</creator><creator>Balmer, Nina V</creator><creator>König, André</creator><creator>Kolde, Raivo</creator><creator>Gaspar, John Antonydas</creator><creator>Henry, Margit</creator><creator>Hescheler, Jürgen</creator><creator>Sachinidis, Agapios</creator><creator>Rahnenführer, Jörg</creator><creator>Hengstler, Jan G</creator><creator>Leist, Marcel</creator><general>American Chemical Society</general><scope>N~.</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20140317</creationdate><title>Design Principles of Concentration-Dependent Transcriptome Deviations in Drug-Exposed Differentiating Stem Cells</title><author>Waldmann, Tanja ; Rempel, Eugen ; Balmer, Nina V ; König, André ; Kolde, Raivo ; Gaspar, John Antonydas ; Henry, Margit ; Hescheler, Jürgen ; Sachinidis, Agapios ; Rahnenführer, Jörg ; Hengstler, Jan G ; Leist, Marcel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a464t-ac36f173b3eb6418273b2a58faefa3c6d83e131dec11442edcc4b0ff25040fcb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Binding Sites</topic><topic>Cell Differentiation - drug effects</topic><topic>Cells, Cultured</topic><topic>Cluster Analysis</topic><topic>Down-Regulation - drug effects</topic><topic>Embryonic Stem Cells - cytology</topic><topic>Embryonic Stem Cells - drug effects</topic><topic>Embryonic Stem Cells - metabolism</topic><topic>Humans</topic><topic>Neural Plate - cytology</topic><topic>Neural Plate - metabolism</topic><topic>Principal Component Analysis</topic><topic>Transcription Factors - genetics</topic><topic>Transcription Factors - metabolism</topic><topic>Transcriptome - drug effects</topic><topic>Up-Regulation - drug effects</topic><topic>Valproic Acid - chemistry</topic><topic>Valproic Acid - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Waldmann, Tanja</creatorcontrib><creatorcontrib>Rempel, Eugen</creatorcontrib><creatorcontrib>Balmer, Nina V</creatorcontrib><creatorcontrib>König, André</creatorcontrib><creatorcontrib>Kolde, Raivo</creatorcontrib><creatorcontrib>Gaspar, John Antonydas</creatorcontrib><creatorcontrib>Henry, Margit</creatorcontrib><creatorcontrib>Hescheler, Jürgen</creatorcontrib><creatorcontrib>Sachinidis, Agapios</creatorcontrib><creatorcontrib>Rahnenführer, Jörg</creatorcontrib><creatorcontrib>Hengstler, Jan G</creatorcontrib><creatorcontrib>Leist, Marcel</creatorcontrib><collection>American Chemical Society (ACS) Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Chemical research in toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Waldmann, Tanja</au><au>Rempel, Eugen</au><au>Balmer, Nina V</au><au>König, André</au><au>Kolde, Raivo</au><au>Gaspar, John Antonydas</au><au>Henry, Margit</au><au>Hescheler, Jürgen</au><au>Sachinidis, Agapios</au><au>Rahnenführer, Jörg</au><au>Hengstler, Jan G</au><au>Leist, Marcel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design Principles of Concentration-Dependent Transcriptome Deviations in Drug-Exposed Differentiating Stem Cells</atitle><jtitle>Chemical research in toxicology</jtitle><addtitle>Chem. Res. Toxicol</addtitle><date>2014-03-17</date><risdate>2014</risdate><volume>27</volume><issue>3</issue><spage>408</spage><epage>420</epage><pages>408-420</pages><issn>0893-228X</issn><eissn>1520-5010</eissn><abstract>Information on design principles governing transcriptome changes upon transition from safe to hazardous drug concentrations or from tolerated to cytotoxic drug levels are important for the application of toxicogenomics data in developmental toxicology. Here, we tested the effect of eight concentrations of valproic acid (VPA; 25–1000 μM) in an assay that recapitulates the development of human embryonic stem cells to neuroectoderm. Cells were exposed to the drug during the entire differentiation process, and the number of differentially regulated genes increased continuously over the concentration range from zero to about 3000. We identified overrepresented transcription factor binding sites (TFBS) as well as superordinate cell biological processes, and we developed a gene ontology (GO) activation profiler, as well as a two-dimensional teratogenicity index. Analysis of the transcriptome data set by the above biostatistical and systems biology approaches yielded the following insights: (i) tolerated (≤25 μM), deregulated/teratogenic (150–550 μM), and cytotoxic (≥800 μM) concentrations could be differentiated. (ii) Biological signatures related to the mode of action of VPA, such as protein acetylation, developmental changes, and cell migration, emerged from the teratogenic concentrations range. (iii) Cytotoxicity was not accompanied by signatures of newly emerging canonical cell death/stress indicators, but by catabolism and decreased expression of cell cycle associated genes. (iv) Most, but not all of the GO groups and TFBS seen at the highest concentrations were already overrepresented at 350–450 μM. (v) The teratogenicity index reflected this behavior, and thus differed strongly from cytotoxicity. Our findings suggest the use of the highest noncytotoxic drug concentration for gene array toxicogenomics studies, as higher concentrations possibly yield wrong information on the mode of action, and lower drug levels result in decreased gene expression changes and thus a reduced power of the study.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>24383497</pmid><doi>10.1021/tx400402j</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0893-228X |
ispartof | Chemical research in toxicology, 2014-03, Vol.27 (3), p.408-420 |
issn | 0893-228X 1520-5010 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3958134 |
source | ACS Publications; MEDLINE |
subjects | Binding Sites Cell Differentiation - drug effects Cells, Cultured Cluster Analysis Down-Regulation - drug effects Embryonic Stem Cells - cytology Embryonic Stem Cells - drug effects Embryonic Stem Cells - metabolism Humans Neural Plate - cytology Neural Plate - metabolism Principal Component Analysis Transcription Factors - genetics Transcription Factors - metabolism Transcriptome - drug effects Up-Regulation - drug effects Valproic Acid - chemistry Valproic Acid - toxicity |
title | Design Principles of Concentration-Dependent Transcriptome Deviations in Drug-Exposed Differentiating Stem Cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T03%3A49%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design%20Principles%20of%20Concentration-Dependent%20Transcriptome%20Deviations%20in%20Drug-Exposed%20Differentiating%20Stem%20Cells&rft.jtitle=Chemical%20research%20in%20toxicology&rft.au=Waldmann,%20Tanja&rft.date=2014-03-17&rft.volume=27&rft.issue=3&rft.spage=408&rft.epage=420&rft.pages=408-420&rft.issn=0893-228X&rft.eissn=1520-5010&rft_id=info:doi/10.1021/tx400402j&rft_dat=%3Cproquest_pubme%3E1524411226%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1524411226&rft_id=info:pmid/24383497&rfr_iscdi=true |